• In recent weeks, a series of partners including Bliss Baby, Tru Niagen, Zigglebee, PiiPER, Nurture Life, Diya Beauty and Wellness, Mighty Paw, Magic Science Corporation, Kate Farms, and Edible Garden announced launches or expansions of their products into Walmart stores and Walmart.com, while Walmart has also been identified as eligible for a very large tariff refund following a Supreme Court ruling.
• These developments highlight Walmart’s growing role as a platform for health, wellness, family, and lifestyle brands and underscore the scale of its e-commerce and omnichannel reach, including US$27.10 billion in U.S. e-commerce net sales and US$16.40 billion in U.S. health and wellness net sales in the quarter ended April 30 2026.
• We’ll now examine how Walmart’s expanding health, wellness, and kids-focused assortment, together with the prospective tariff refund, may influence its investment narrative.

AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Walmart Investment Narrative Recap

To own Walmart today, you need to believe in its ability to convert massive traffic across stores and digital channels into higher margin omnichannel and services income, while keeping costs in check. The latest wave of partner launches and the potential US$2.4 billion tariff refund do not materially change that near term, but they do touch both sides of the story: they reinforce the e-commerce and health focus, and modestly ease ongoing tariff and cost pressures.

Among the recent announcements, Tru Niagen’s rollout on Walmart.com best captures this shift, sitting at the intersection of Walmart’s health and wellness push and its large digital platform. It lands on top of U.S. e-commerce net sales of US$27.10 billion and U.S. health and wellness net sales of US$16.40 billion last quarter, tying directly into the key catalyst of scaling higher value omnichannel activity while working against the risk that e-commerce and delivery costs continue to pressure profitability.

But even as investors focus on tariff refunds, you still need to be aware of the ongoing pressure from...

Walmart's narrative projects $832.5 billion revenue and $29.3 billion earnings by 2029. This requires 4.7% yearly revenue growth and a $6.6 billion earnings increase from $22.7 billion.

Uncover how Walmart's forecasts yield a $138.37 fair value, a 24% upside to its current price.

Exploring Other Perspectives

Seventeen members of the Simply Wall St Community value Walmart between US$93.94 and US$154.58, showing a wide spread in individual expectations. Against that diversity, Walmart’s push into higher margin e-commerce and health offerings could be important for how you think about its longer term earnings power and resilience.

Explore 17 other fair value estimates on Walmart - why the stock might be worth 16% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Walmart research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Walmart research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Walmart's overall financial health at a glance.

Seeking Other Investments?

Our top stock finds are flying under the radar-for now. Get in early:

• The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.